TRial of Atorvastatin for the primary prevention of Cardiovascular Events in Rheumatoid Arthritis
Phase of Trial: Phase III
Latest Information Update: 13 Jun 2015
At a glance
- Drugs Atorvastatin (Primary)
- Indications Cardiovascular disorders
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- Acronyms TRACE-RA; TRACE-RA-Biobank; TRACE-RA-DAS
- 13 Jun 2015 The trial had been discontinued according to the abstract presented at 16th Annual Congress of the European League Against Rheumatism.
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism (n = 2986).
- 20 Mar 2015 Accrual to date 60% reported by United Kingdom Clinical Research Network record